Announcements

Prashant B. Rawat, Chief Operating Officer of Mobia Medical, Inc. (NASDAQ:MOBI), filed a statement of changes in beneficial ownership on September 4, 2026, reporting a stock option exercise transaction dated September 2, 2026.

Ryan R. Craig, Executive Vice President and Chief Human Resources Officer of Elevance Health, Inc., filed a Form 4 on September 4, 2026, reporting a disposition of common stock on September 2, 2026, related to restricted stock vesting.

Erin M. Wessling, Executive Vice President and Chief Legal Officer of Elevance Health, Inc., filed a Form 4 on September 4, 2026, disclosing two transactions involving the withholding of common shares to cover tax liabilities upon the vesting of previously granted restricted stock.

Director Jennifer N. Pritzker filed a Form 4 with the SEC on September 4, 2026, disclosing the sale of 22,500 shares of OrthoPediatrics Corp common stock on September 2, 2026, executed through Squadron Capital LLC.

David R. Pelizzon, a director and 10% owner of OrthoPediatrics Corp, filed a Form 4 on September 4, 2026, reporting the sale of 22,500 shares of common stock on September 2, 2026, executed through Squadron Capital LLC.

Timothy James Last, Executive Vice President of Sales and Marketing at Iridium Communications Inc., filed a Form 4 on September 4, 2026, disclosing the sale of 2,013 shares of common stock on September 3, 2026.

A Form 4 filed on September 4, 2026, discloses that J. Anthony Ware, a director of First Tracks Biotherapeutics, Inc., exercised stock options and sold common shares on September 2, 2026.